Affiliation:
1. Department of Chemistry , 175504 Universitas Lampung , Bandar Lampung , 35415 , Indonesia
2. MAN 1 , Pringsewu , Lampung , Indonesia
Abstract
Abstract
In this work, three organotin (IV) derivatives namely dibutyltin(IV) di-2-hydroxybenzoate (DBT2-HBz) (2), dibutyltin(IV) di-3-hydroxybenzoate (DBT3-HBz) (3) and dibutyltin(IV) di-4-hydroxybenzoate (DBT4-HBz)) (4) were synthesized and tested as disinfectant against pathogenic bacteria, Staphylococcus aureus. Compounds 2–4 were prepared by reacting dibutyltin(IV) oxide (DBTO) (1) with 2-hydroxybenzoic acid (2-HHBz), 3-hydroxybenzoic acid (3-HHBz) and 4-hydroxybenzoic acid (4-HHBz). The synthesized compounds were characterized by spectroscopic techniques including UV–Vis, FT-IR, 1H NMR, and 13C NMR, and micro-elemental analyzer. The optical density (OD) of compounds was measured by UV–Vis at 600 nm, which showed good bioactivity against the S. aureus. The data obtained indicated that compound 4 has higher bioactivity than compound 2 and 3, and the positive control using a commercial disinfectant containing 5 % benzalkonium chloride. The optimum bioactivity of compound 4 was observed at a concentration of 5 × 10−4 M with a contact time of 10 min, as shown by the decrease in absorbance from 0.6092 to 0.4005. Compound 2 was optimal at a concentration of 5 × 10−4 M with a contact time of 10 min, and the absorbance decreased from 0.6092 to 0.4416. Compound 3 and positive control showed a smaller decrease in absorbance compared to compound 4 and 2. Overall, the results obtained indicated that the compounds synthesized have promising potential as disinfectant against pathogenic bacteria.
Funder
Direktorat Jenderal Pendidikan Tinggi
Reference39 articles.
1. J. Davies, D. Davies. Microbiol. Mol. Biol. Rev. 74(3), 417 (2010), https://doi.org/10.1128/mmbr.00016-10.
2. S. Hadi, E. Hermawati, N. Noviany, T. Suhartati, Y. Yandri. Asian J. Microbiol. Biotech. Env. Sci. 20, 113 (2018).
3. G. F. Brooks, K. C. Carrol, J. S. Butel, S. A. Morse, T. A. Mietzner. Jawetz, Melnick & Adelberg’s Medical Microbiology, p. 149, McGraw-Hill, New York, 26th ed. (2013).
4. J. M. Besser. Food Microbiol 71, 55 (2017), https://doi.org/10.1016/j.fm.2017.08.018.
5. S. Y. C. Tong, J. S. Davis, E. Eichenberger, T. L. Holland, V. G. Fowler. Clin. Microbiol. Rev. 28(3), 603 (2015), https://doi.org/10.1128/cmr.00134-14.